Article
Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM.
Diabetic medicine : a journal of the British Diabetic Association - 1 Nov 1995
Nagi D K, Mansfield M W, Stickland M H, Grant P J
Abstract excerpt
Angiotensin 1 converting enzyme (ACE) catalyses the step which generates angiotensin II, and also inactivates bradykinin, peptides which play a key role in modulating vascular tone. Plasma ACE levels are under genetic control and up to 50% of the variation is due to an insertion/deletion (I/D) polymorphism of ACE gene with highest levels found in DD homozygotes. Studies have shown an association of diabetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
